Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research focused on Cancer research and Osteosarcoma, with related work in Oncogene, microRNA, Tumor microenvironment. Notable publications include 'Syndecan-2 in colorectal cancer plays oncogenic role via epithelial-mesenchymal transition and MAPK pathway', 'Comprehensive Proteomic Characterization of the Human Colorectal Carcinoma Reveals Signature Proteins and Perturbed Pathways', and 'miR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN'.
Tumor microenvironment responsive nano-PROTAC for BRD4 degradation enhanced cancer photo-immunotherapy
In situ vascularization and epithelialization of segmental bioengineered trachea based on marrow-derived stem/progenitor cells
Extracellular Vesicles in the Repair of Bone and Cartilage Injury: From Macro‐Delivery to Micro‐Modification
Prediction models of surgical site infection after gastrointestinal surgery: a nationwide prospective cohort study
Construction of a novel cell-free tracheal scaffold promoting vascularization for repairing tracheal defects
MicroRNA-95-3p serves as a contributor to cisplatin resistance in human gastric cancer cells by targeting EMP1/PI3K/AKT signaling
Syndecan-2 in colorectal cancer plays oncogenic role via epithelial-mesenchymal transition and MAPK pathway
miR-27a-3p promotes the malignant phenotypes of osteosarcoma by targeting ten-eleven translocation 1
Comprehensive Proteomic Characterization of the Human Colorectal Carcinoma Reveals Signature Proteins and Perturbed Pathways
Downregulation of 14-3-3β inhibits proliferation and migration in osteosarcoma cells
Downregulation of NKD1 in human osteosarcoma and its clinical significance
miR-221 increases osteosarcoma cell proliferation, invasion and migration partly through the downregulation of PTEN
Activin A regulates proliferation, invasion and migration in osteosarcoma cells
Expression of RKIP in chronic myelogenous leukemia K562 cell and inhibits cell proliferation by regulating the ERK/MAPK pathway
Gly82Ser polymorphism of the receptor for advanced glycation end-product (RAGE) potential high risk in patients with colorectal cancer